New York City, NY -- (SBWIRE) -- 01/31/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Under Armour Inc (NYSE:UA), Corcept Therapeutics Incorporated (NASDAQ:CORT), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Prana Biotechnology Limited (ADR) (NASDAQ:PRAN)
Under Armour Inc (NYSE:UA) gained 22.93%, trading on 9.09 million shares, to end the trade at $104.76. The stock changed hands in a range of $96.00 to $106.65, bringing its market capitalization to about $11.03 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $46.31 and was moved to the maximum level of $106.65. Under Armour, Inc. (Under Armour) is engaged in the development, marketing and distribution of apparel, footwear and accessories for men, women and youth. The Company’s products are sold worldwide and are worn by athletes at all levels, from youth to professional, on playing fields worldwide.
Why Should Investors Buy UA After The Recent Gain? Just Go Here and Find Out
Corcept Therapeutics Incorporated (NASDAQ:CORT) added 22.70%, to complete the trading session at $3.73, with a total volume of 1.06 million shares. The stock, on average, trades on a volume of 464,874 shares. It floated in a range of $3.03 to $3.76 during the last trading session, with a beta value of 0.82. Its market capitalization now moved to about $372.31 million. In the past 52 weeks, the share price has not declined below $1.47 and above $3.83. Corcept Therapeutics Inc is a United States-based pharmaceutical company. The Company is involved in the discovery and development of drugs that regulate the effects of cortisol or also known as the stress hormone. Founded on 1998, it has focused its research and clinical development activity on drugs that block the glucocorticoid receptor or GR-II receptor, one of the bodys two receptors of cotrisol.
What was the Moving Force behind CORT on Bullish Run? Read This Research Report
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) recorded a gain of 21.14% and was in a range of $154.00-$169.98 before closing at $162.00. The stock completed the day with a total volume of 5.80 million shares, versus an average volume of 1.14 million shares. The share price hit its 52-week low of $81.82 and $169.98 was the best price. Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company focused on serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its marketed product Soliris (eculizumab) is the first and only therapeutic approved for patients with two ultra-rare and severe disorders resulting from chronic uncontrolled activation of the complement component of the immune system.
For How Long ALXN will fight for Profitability? Read This Trend Analysis report
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) added 20.53% yesterday, bringing its market capitalization around $502.33 million. The share price, after opening at $10.65, made a high of $13.29 and hovered above $9.91 to end the day at $12.33. The total number of shares that changed hands during the session was 5.41 million shares, as compared to average trading volume of 817,566 shares. Prana Biotechnology Limited (Prana) is development stage company. The Company is engaged in develop therapeutic drugs designed to treat the underlying causes of degeneration of the brain and the eye as the aging process progresses, initially focusing on Alzheimer’s disease.
For How Long PRAN Gloss will Attract Investors? Find out via this report
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)